17 Aug 2007 - Corning Incorporated announced that it has acquired from Oerlikon the worldwide exclusive rights to U.S. Patent 5,738,825 and its foreign counterparts, which cover microplate-based optical biosensors. Corning had previously acquired a joint ownership right in the patent from Artificial Sensing Instruments, AG of Switzerland as part of a broader technology exchange. By acquiring these exclusive rights in the patent from Oerlikon, Corning will not only have the right to continue to practice the technology disclosed, but will now also have the full right to enforce the patent.
"We are pleased to expand our portfolio of enforceable patents as we continue to invest in this exciting commercial opportunity," stated Dr. Jeff Mooney, commercial technology director for Corning Life Sciences.
 |
www.bionity.com/news/e/67209 |
|
 |
|
|
© Chemie.DE Information Service GmbH http://www.bionity.com/news/e/67209 |
Seydelstr. 28 · 10117 Berlin info@chemie.de · Tel: +49 (0)30 20 45 68 - 0 |